← SynDRA
KETOPROFEN
SynDRA canonical compound SYN0000885 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | PTGS2 |
|---|
| Mechanism of action | Cyclooxygenase inhibitor |
|---|
| Indication | osteoarthritis | rheumatoid arthritis |
|---|
| Disease area | rheumatology |
|---|
All known targets
Mechanisms of action (all sources)
- Cyclooxygenase inhibitor
- PTGS2 INHIBITOR
- PTGS1 INHIBITOR
- SLC5A8 INHIBITOR
Drug classes
- Cyclooxygenase Inhibitors
- Analgesics
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Antirheumatic Agents
- Enzyme Inhibitors
- Peripheral Nervous System Agents
- Sensory System Agents
- Nonsteroidal Anti-inflammatory Drug
ATC classes
- M01A · ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
- M02A · TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
Cross-references
Synonyms
- RP-19583
- ketoprofene
- ketoprophen
- Ketoprofene
- Ketoprofeno
- (rs)-ketoprofen
- Actron ketoprofen
- Aneol
- Capisten
- Hydratropic acid, m-benzoyl-
- Iso-k
- Ketorin
- Sector
- 19583RP
- IDEA-033
- NSC-758144
- R.P. 19,583
- R.P. 19583
- RU-4733
- Actron
- Alrheumat
- Axorid
- Fenoket 200
- Jomethid xl
- Ketocid 200
- Ketonal
- Ketotard 200 xl
- Ketovail
- Ketozip 200 xl
- Larafen
- Larafen cr
- Nexcede
- Orudis
- Orudis 100
- Orudis kt
- Oruvail
- Oruvail 100
- Oruvail 150
Reported adverse events
- Rash
- Peptic ulcer
- Dyspepsia
- Headache
- Thirst
- Alopecia
- Amnesia
- Arrhythmia
- Chills
- Conjunctivitis
- Diabetes mellitus
- Dysphoria
Look up KETOPROFEN in the interactive SynDRA portal →